Consumable momentum, ambitious manufacturing pivots ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade B
Management reiterated >20% FY'27 growth guidance; delivered 21% in H1. EBITDA margin target 14-15% beaten at 17.7%—conservative on expense assumptions.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
H1 delivered strong revenue growth (21.1% YoY) with profit acceleration (+43.3%) driven by consumable mix shift—the business model is working. Two large backward-integration JVs (INKIA ink, Swastik coated paper, ₹360+ Cr capex) position the company for multi-year consumable tail growth and margin expansion. Key risk: execution on manufacturing; receivables at ₹116 Cr remain a focus area despite improved collection discipline.
₹183.01 Cr
Revenue · +21.1% YoY₹21.09 Cr
Reported PAT · +43.3% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Profit growing twice as fast as revenue; consumable mix expanding
METRevenue +21.1% YoY, PAT +43.3% YoY; consumable % of revenue rose from 48.7% to 56.2%
Operating cash flow turned positive
METH1 FY'27 OCF ₹27.16 Cr vs outflow ₹10.90 Cr H1 FY'26; receivables stable at ₹116 Cr despite 20%+ growth
Sublimation paper volume doubled
METVolume rose from 4.92 to 9.97 Cr meters (+102.4%); revenue +79% to ₹51.81 Cr
Ink manufacturing starting in-house via INKIA JV by FY'27 end
MET150 tons/month capacity targeted by FY'27 end at CapEx ₹40-45 Cr; currently 80 tons/month via INKIA partnership
Earnings quality
What changed since the last call
Consumable % of revenue expanded
UpgradeRose from 48.7% to 56.2%; ink & paper now largest segment. Margin accretion clear in PAT +43% vs revenue +21%.
Working capital turned positive
UpgradeOCF +₹27.16 Cr vs -₹10.90 Cr YoY; receivables stable despite >20% revenue growth. MSME supplier shift now paying off.
Two major JVs announced
NewINKIA (50-50, ₹40-45 Cr capex) + Swastik coated-paper (50-50, ₹320-340 Cr capex). Backward integration play; both under Viksit Gujarat policy.
The Q&A
Analysts pushed hard on receivables (3 questions), machine sales, capability to manage ₹360+ Cr capex simultaneously, and INKIA valuation. Management held firm, citing improved collection, disclosed capacity constraints, and highlighted Swastik's execution track record. Tone: confident but willing to acknowledge execution risks.
Equity raise, project funding — Keshav Garg, Counter Cyclical PMS
AnsweredINKIA: 50-50 equity/debt split, 25% equity on total capex. Coated-paper JV: 25% equity, 75% project debt. Open to equity if value-accretive; not restricted to one funding route.
Receivables & collection risk — Keshav Garg, Counter Cyclical PMS
AnsweredH1 FY'26 receivables ₹92 Cr at April-May; improved by June. H1 FY'27 ₹116 Cr on ₹183 Cr revenue; payment cycle now 90-120 days (normal industry). Receivables under control vs revenue growth.
FY'27 guidance, margin expectations — Keshav Garg, Counter Cyclical PMS
AnsweredRevenue: 20-22% growth (reiterated); margins improving due to consumable mix. Will try to match H2 performance.
Printhead replacement, machine upgrade — Vishal Prasad, Raj Mahal Capital
AnsweredTypically an upgrade (printhead + minor mechanical work). Customers want to jump from 2,000 to 10,000 meters/day = new machine. Upgrade = recurring revenue driver.
Paper manufacturing moat, sourcing risks — Vishal Prasad, Raj Mahal Capital
PartialBase paper sourcing is technology + supply constraint. India imports 70-75% of sublimation paper. JV gives us control over base paper, coating, and GSM consistency—globally competitive at scale.
Ink sourcing & customer lock-in — Vishal Prasad, Raj Mahal Capital
PartialINKIA formulation capability (started with R&D) can match any color. 99% of digital ink imports are white-label. Customers can switch if we match color + maintain consistency. Advantage: long-term service relationship.
Ink pricing, supply, margin — Madhur Rathi, Counter Cyclical Investments
AnsweredPigment price rise is global; volume rising but price corrected down globally. Focus is on installing base which drives recurring revenue. Margin improvement comes from consumables shift, not ink pricing.
Paper segment, capex rationale — Madhur Rathi, Counter Cyclical Investments
AnsweredBase paper is capacity/quality constraint in India. Sublimation paper is niche, not competing with commodity mills. Backward integration gives control over GSM, supply, and margin.
Margin trajectory on consumables, manufacturing margins — Rohan (Individual Investor)
PartialMachine: ~5% margin (recurring revenue platform). Consumables: ~25-35% depending on product. EBITDA margin consolidated 17%; mix shift drives improvement. INKIA adds margin through internalization.
Machine installed base trajectory — Kaushal Aggarwal, Veera Bharat Opportunities
AnsweredCapacity constraint, not demand. Previous 1 Cr meter/month capacity extended to 2 Cr meter/month. Machine sales lumpy; Q2 > Q1. Guidance stable at >20% growth for FY'27.
Installed base composition, sublimation vs reactive — Naveen (Individual Investor)
Answered70-75% sublimation, 25-30% reactive. Over time, ratio moving toward sublimation. Polyester demand rising; cotton traditional; direct printing still higher-cost.
INKIA merger, valuation, FY'27 numbers — Rohan (Individual Investor)
PartialBSE approval 3-4 months away. NCLT in progress. Merger likely before year-end or early FY'28. Valuation ₹60 Cr at ₹240/share (marked from ₹19x IPO). FY'27 INKIA revenue ₹24 Cr, PAT ₹4 Cr (rough estimate; waiting for merger approval to finalize).
INKIA ink capacity, sourcing for True Colors — Rohan (Individual Investor)
Answered80 tons/month currently. First priority: True Colors ecosystem (140-150 tons at peak). Once 150 ton capacity live, 35-40% may be True Colors, rest OEM. Flexibility to replace imports once internal capacity scales.
Swastik JV, partner background, execution risk — Kaushal Aggarwal, Veera Bharat Opportunities
AnsweredSwastik: Surat-based, textile + infrastructure/construction. JV formed Oct 2026 (3 months ago). Proven project execution track record. True Colors brings sublimation-paper expertise; Swastik brings project management + balance-sheet strength. 50-50 equity structure.
Guidance
FY27 >20% growth
HighReiterated from start of year. H1 delivered 21.1% on track.
EBITDA margin 14-15% consolidated
MediumH1 delivered 17.7%, beating guidance; driven by consumable mix. May sustain if consumable % continues to rise.
INKIA ₹40-45 Cr for 150 tons/month ink capacity by FY'27 end
MediumSwastik partnership 50-50 equity/debt; likely funded from internal cash + debt.
Coated-paper JV ₹320-340 Cr for 8-10 Cr meters/month by H2 FY29
Medium25% equity, 75% project debt; under Viksit Gujarat policy (25% subsidy on capex).
Risks the call surfaced
Execution risk (JV capex)
Medium₹360+ Cr capex across two JVs over 2-3 years. Swastik partnership only 3 months old. Coated-paper production by H2 FY29 is aggressive.
Receivables & working capital
Medium₹116 Cr receivables on ₹183 Cr H1 revenue (63-day DSO); still elevated despite improvements. Lumpy machine sales & capex may stress cash.
Supply constraint (paper)
MediumIndia imports 70-75% of sublimation paper. Global price correction ongoing. Coated-paper manufacturing capex is hedge, but timing uncertain (H2 FY29).
Machine sales cyclicality
LowMachine revenue declining 18-19% YoY despite strong consumable growth. Installed base 956 units growing 11% YoY; upside may be limited if base matures.
Ink supplier lock-in (customer)
LowCustomer switching cost for ink color is high but not absolute. INKIA formulation capability exists; but if customers defect to alternate suppliers, recurring revenue at risk.
Management
Score 7/10. Clear on business model mechanics; detailed technical explanations on moats, supply chain, and manufacturing. Transparent on execution risks; deferred some specifics pending approvals (INKIA numbers, receivable >180 days). Beat FY'27 revenue guidance in H1 (+21.1% vs >20%). EBITDA margin exceeded target (17.7% vs 14-15%). Turned OCF positive after working capital issues. Track record credible, but two large JVs not yet in execution phase.
1 · H2 FY27
INKIA ink manufacturing ramp to 150 tons/month
2 · FY28
INKIA Phase-2 (500 tons/month); coated-paper JV foundation stage
3 · H2 FY29
Coated-paper JV commercial production (8-10 Cr meters/month)
Key risk: execution on manufacturing; receivables at ₹116 Cr remain a focus area despite improved collection discipline.
Profit surges 43% on consumable mix, but the real test is ₹360 Cr of capex ahead
True Colors delivered revenue and margin guidance on the back of a deliberate mix shift toward consumables—and the market has halved the stock from its highs. The earnings call reveals why: while the quarter is solid, two unproven JVs with ₹360+ crore capex carry execution risk the street is pricing in.
The quarter at a glance
₹183.01 Cr
+21.1% YoY
₹21.09 Cr
+43.3% YoY · profit growth 2x revenue
17.7%
+240 bps YoY; beat 14-15% guidance
56.2%
up from 48.7%; ink + paper now core
₹27.16 Cr
vs outflow ₹10.90 Cr YoY
₹116.03 Cr
63-day DSO; improved but elevated
True Colors' Q2 narrative is one of surgical execution: the company has shifted its revenue mix deliberately toward high-margin consumables (ink and paper), and the math is working. Profit growing 2x revenue is not an accident—it's the intended outcome of a business model redesign that's been in motion for 18 months. Operating cash flow turned positive for the first time in recent history, receivables stabilized despite 21% revenue growth, and the installed base of printing machines (956 units) continues to drive recurring ink and paper demand.
But the market has halved the stock from its all-time high of ₹271.95, and the earnings call is the reason: management has laid out ₹360+ crore in capex across two backward-integration JVs over the next three years, and the company must execute both while scaling consumables 20%+ annually. The call shows confidence, but not certainty.
What the profit growth actually reflects
Reported PAT of ₹21.09 Cr grew 43.3% YoY while revenue grew 21.1%. This is not a margin miracle or a one-time gain—it's the outcome of a mix shift. Consumables revenue grew faster (sublimation paper +79% to ₹51.81 Cr, ink volume +22% to 689 tons), while lower-margin machines contributed less to the top line. Gross margin expanded 405 basis points to 30.2%; EBITDA margin improved 240 basis points to 17.7%, beating the company's own 14-15% guidance.
Management's claims vs. what holds up
Profit growing twice as fast as revenue; consumable mix expanding
Revenue +21.1% YoY, PAT +43.3% YoY; consumable % of revenue rose from 48.7% to 56.2%
Supported
Operating cash flow turned positive
H1 FY'27 OCF ₹27.16 Cr vs outflow ₹10.90 Cr H1 FY'26; receivables stable at ₹116 Cr despite >20% growth
Supported
Sublimation paper volume doubled
Volume rose from 4.92 Cr meters to 9.97 Cr meters (+102.4%); revenue +79% to ₹51.81 Cr
Supported
Receivables under control via improved MSME payment discipline
₹116 Cr on ₹183 Cr revenue = 63-day DSO; improved from April-May stretch but still above Indian best-in-class (45-60 days)
Partially supported · improved but elevated
INKIA and Swastik partnerships will drive margin expansion via backward integration
INKIA 50-50 JV, 150 tons/month by FY27-end, ₹40-45 Cr capex approved; Swastik coated-paper JV, 8-10 Cr meters/month by H2 FY29, ₹320-340 Cr capex—partnerships only in formation stage
Supported in concept · unproven in execution
What changed on this call
Consumable revenue mix jumped 7 points to 56%; sublimation paper doubled, ink consumption scaled 22%
Operating cash flow swung from -₹10.90 Cr (H1 FY'26) to +₹27.16 Cr (H1 FY'27)—a ₹37 Cr improvement
Two major backward-integration JVs announced: INKIA (ink, 50-50 with Spain partner, ₹40-45 Cr capex) and Swastik (coated-paper, 50-50 with Surat-based infrastructure firm, ₹320-340 Cr capex)
Machine revenue declining 18-19% YoY while consumable revenue surges—active pivot away from hardware-centric model
The bull-bear ledger
Consumable mix is durable: recurring revenue from installed base (956 machines, 11% YoY growth) drives 25-35% margin ink and paper sales; model is self-reinforcing
Guidance credibility strong: H1 delivered 21.1% revenue growth vs. >20% target; EBITDA margin 17.7% vs. 14-15% target; management conservative on assumptions
OCF turnaround validates working capital fix: receivables improved by June despite 21% growth; MSME supplier payment discipline restored
Reported profit leans on consumable mix shift, not multiple expansion or one-time items—organic and repeatable
₹360+ Cr capex across two unproven JVs over 3 years; Swastik partnership only 3 months old; execution risk material
Receivables still 63-day DSO despite improvements; if receivables cycle stretches again, OCF could reverse
Machine sales declining 18-19% YoY; if installed base matures and machine replacement cycles slow, consumable growth may plateau
FII ownership crashed from 2.30% to 0.77% YoY; DII trimmed from 10.80% to 8.67%; institutional selling during earnings—signal of conviction loss
Stock down 46.31% from all-time high; trading below SMA50 and SMA200; volume trending down; market sentiment bearish despite fundamentals
How the street is positioned
Price and trend: True Colors closed at ₹146, down 46.31% from its all-time high. The stock sits above its 20-day moving average (₹143) but below its 50-day (₹146.53) and 200-day (₹159.29) averages. RSI at 50.7 is neutral—no oversold spike yet, but no strength either. Volume is trending down, suggesting weak conviction in either direction.
Institutional flows: Foreign institutional investors have exited sharply—ownership fell from 2.30% in Q2 FY'26 to 0.77% in Q4 FY'26 (a decline of 153 basis points). Domestic institutions also trimmed: DII ownership fell from 10.80% to 8.67% (down 213 basis points). Promoter holding is stable at 68.89%, up 1 basis point. The institutional exit during a quarter that delivered on guidance is striking—it suggests the market is pricing in capex execution risk or a loss of faith in management's ability to deploy ₹360+ Cr without margin compression.
The disconnect: Fundamental momentum is real—revenue and profit guidance met, mix shift working, OCF positive—yet the stock has halved from its highs and institutional buyers are absent. The market is asking: can the company execute two large JVs while scaling consumables 20%+ annually? And if capex delays or stumbles, where is the margin hedge? The 46% drawdown is pricing in significant execution risk.
Risks, ranked by how much they should concern a holder
Capex execution on two large JVs (₹360+ Cr over 3 years); Swastik partnership only 3 months old
HighIf either JV misses its production ramp (INKIA 150 tons/month by FY27-end, coated-paper by H2 FY29), margin expansion targets are missed and capital efficiency is questioned. Simultaneous execution of both JVs while scaling consumables 20%+ is unproven.
Receivables cycle re-stretch; 63-day DSO still elevated despite improvements
HighOCF turnaround is real, but depends on MSME supplier payment discipline holding. If receivables cycle stretches again (as it did in April), OCF could reverse and capital for JVs must come from debt, raising leverage.
Machine sales continue to decline; installed base may be maturing
MediumMachine revenue down 18-19% YoY despite consumable growth. If installed base growth slows or machine replacement cycles extend, the consumable revenue driver could plateau. Management silent on machine trajectory and guidance.
India import dependency on sublimation paper remains (70-75% of India's supply is imported); global pricing pressure ongoing
MediumCoated-paper JV is a 3-year hedge. Until H2 FY29, the company remains exposed to import pricing swings and supply constraints. If Chinese manufacturers cut prices aggressively, consumable margin could compress.
Institutional investor exodus; FII and DII ownership down sharply
MediumFII down 153 bps, DII down 213 bps. Institutional investors are voting with their feet. If the sell-off accelerates, liquidity could become an issue, and the stock could trade on technicals rather than fundamentals.
The debate
What to watch next
1 · INKIA ink capacity ramp to 150 tons/month by FY27-end
This is the first proof point. If INKIA hits 150 tons/month by year-end (from 80 tons/month today), it validates management's execution capability and reduces the import dependency story. Delay or miss here triggers broad capex skepticism.
2 · Swastik coated-paper JV foundation stage by H1 FY28
Swastik is a 3-month-old partnership, so progress will be watched closely. Foundation stage commencement (land acquisition, equipment orders, technical hiring) by H1 FY28 is the next checkpoint. Slippage here risks the H2 FY29 commercial production target.
3 · Receivables DSO improvement and OCF sustainability
OCF turning positive is the biggest Q2 win, but it depends on receivables staying at 63 days. Next quarter's receivables and OCF will show if the MSME payment discipline is structural or cyclical. A return to 80+ days would undermine the capex funding thesis.
The single number to track
From this quarter forward, track operating cash flow. It's the single metric that tells you whether the company can self-fund its capex ambitions or if leverage is rising. OCF of ₹27.16 Cr is strong, but it needs to hold above ₹20 Cr run-rate in subsequent quarters for the capex thesis to work. If receivables re-stretch and OCF dips below ₹15 Cr, the margin expansion story breaks and the ₹360+ Cr capex becomes a debt-funded risk.
True Colors delivered a solid Q2: consumable mix is shifting as planned, OCF is positive, and guidance is on track. But the company is now asking the street to trust it with ₹360+ Cr of capex, and the market has halved the stock while exiting institutional positions. The quarter is not a step-change—it's steady execution of a two-year-old plan. The debate is not about Q2; it's about whether the next two years of capex prove the business model or break it. For holders, the 46% drawdown is a warning flag; for believers in the backward-integration thesis, it's an entry point. The price will resolve as each JV milestone passes. Consumable growth is real and defensible, but capex execution is the gating item now.